Profile data is unavailable for this security.
About the company
Thai Optical Group Public Company Limited is a Thailand-based company. The Company is principally engaged in the manufacture and distribution of organic lenses and related products. Its segments include concentrated, plastic and glasses lenses and others. Its plastic and glass lens segment, which is engaged in producing and selling optical lenses. The Company’s other products and services segment is engaged in the sale of glass mold, trading goods purchased for resale, glasses assembly services and surface treatments of hard coatings and antireflection coating service for organic lenses. Its product lines include standard lenses, value-added lenses, prescription lenses, and other lens-related products. The Company offers lens designs, lens materials, sun filter lens, coating, photochromic lens, and eyewear for colorblindness. The Company's subsidiaries include Thai Optical Company Limited, Poly Sun Company Limited, TOG USA, Inc., and TOG Europe Sp. z o.o.
- Revenue in THB (TTM)3.12bn
- Net income in THB424.51m
- Incorporated1991
- Employees951.00
- LocationThai Optical Group PCL15/5 Mu 6Bangbuathong-Suphanburi RoadLahan, BangbuathongNONTHABURI CITY 11110ThailandTHA
- Phone+66 21941145
- Fax+66 29255710
- Websitehttps://www.thaiopticalgroup.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cyclopharm Limited | 789.61m | -115.26m | 4.49bn | 87.00 | -- | 4.93 | -- | 5.68 | -0.0508 | -0.0508 | 0.3476 | 0.3428 | 0.6748 | 1.11 | 4.13 | 370,173.10 | -9.85 | -12.60 | -11.92 | -14.94 | 68.15 | 70.20 | -14.60 | -25.47 | 2.32 | -18.40 | 0.1159 | -- | 11.22 | 15.50 | 28.90 | -- | -7.83 | -12.94 |
| EMvision Medical Devices Ltd | 217.24m | -79.07m | 4.52bn | -- | -- | 29.49 | -- | 20.82 | -0.0449 | -0.0449 | 0.1186 | 0.0733 | 0.7954 | -- | -- | -- | -28.95 | -67.20 | -45.25 | -79.38 | -- | -- | -36.40 | -175.99 | -- | -35.20 | 0.3424 | -- | 62.08 | 70.47 | 36.64 | -- | -- | -- |
| Medius Holdings Co Ltd | 57.33bn | 193.83m | 4.58bn | 2.29k | 23.50 | 1.01 | 7.71 | 0.0799 | 38.51 | 38.51 | 11,407.31 | 897.03 | 2.27 | 17.99 | 4.25 | 109,607,600.00 | 0.7673 | 1.64 | 3.17 | 6.02 | 12.05 | 11.49 | 0.3381 | 0.5837 | 0.8993 | 38.74 | 0.5657 | 31.15 | 5.49 | 7.29 | -19.80 | 15.09 | 42.52 | 9.46 |
| Thai Optical Group PCL | 3.12bn | 424.51m | 4.72bn | 951.00 | 11.12 | 2.01 | 7.80 | 1.51 | 0.895 | 0.895 | 6.57 | 4.95 | 0.7988 | 1.59 | 6.52 | 3,279,081.00 | 10.87 | 9.00 | 16.65 | 12.71 | 21.84 | 21.05 | 13.61 | 11.05 | 0.6301 | -- | 0.3528 | 74.32 | 2.43 | 10.20 | 5.46 | 23.86 | 44.55 | 18.35 |
| Bionime Corp | 2.05bn | 7.71m | 4.80bn | 671.00 | 666.22 | 2.23 | 24.53 | 2.34 | 0.1045 | 0.1045 | 29.42 | 31.22 | 0.3527 | 1.99 | 4.09 | -- | 0.1296 | 1.53 | 0.196 | 2.18 | 41.17 | 43.49 | 0.3675 | 3.71 | 0.563 | -0.2416 | 0.5923 | 173.70 | -20.58 | -2.64 | -93.18 | -45.41 | 21.20 | 0.0188 |
| Ziyuanyuan Holdings Group Ltd | 2.52bn | 73.67m | 4.88bn | 184.00 | 61.61 | 2.87 | 34.26 | 1.94 | 0.0391 | 0.0391 | 1.34 | 0.8391 | 0.818 | 44.54 | 3.02 | 2,907,290.00 | 2.28 | 2.61 | 3.67 | 3.71 | 24.69 | -- | 2.78 | 6.13 | 1.75 | 2.34 | 0.313 | -- | 53.41 | 52.48 | -7.90 | -2.98 | 97.56 | -- |
| 4DMedical Ltd | 25.14m | -756.02m | 4.99bn | -- | -- | 2.23 | -- | 198.52 | -0.0882 | -0.0882 | 0.0029 | 0.2332 | 0.0098 | 0.092 | 0.1585 | -- | -29.47 | -43.96 | -39.07 | -57.58 | 95.00 | 32.30 | -3,007.64 | -2,704.36 | 1.79 | -- | 0.0476 | -- | -31.84 | -1.86 | -27.92 | -- | 2.46 | -- |
| IVD Medical Holding Ltd | 15.62bn | 1.20bn | 5.04bn | 803.00 | 4.17 | 0.2978 | 3.63 | 0.3225 | 0.1893 | 0.1893 | 2.45 | 2.65 | 0.6788 | 2.78 | 5.62 | 4,131,733.00 | 5.21 | 5.18 | 6.86 | 6.67 | 21.75 | 20.75 | 7.68 | 7.53 | 1.56 | 7.53 | 0.0923 | -- | 12.35 | 49.49 | 13.41 | 18.15 | 19.77 | -- |
| Aroa Biosurgery Ltd | 1.55bn | -238.50m | 5.04bn | 261.00 | -- | 2.37 | -- | 3.25 | -0.0283 | -0.0283 | 0.1839 | 0.2525 | 0.607 | 1.56 | 2.82 | -- | -9.34 | -10.37 | -10.11 | -12.52 | 85.39 | 80.63 | -15.39 | -20.31 | 6.40 | -- | 0.0726 | -- | 9.01 | 24.26 | -2,583.84 | -- | 33.65 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Norges Bank Investment Managementas of 31 Dec 2023 | 6.98m | 1.47% |
| Aberdeen Asset Management (Thailand) Co., Ltd.as of 28 Dec 2023 | 1.90m | 0.40% |
| Formuepleje A/Sas of 31 Oct 2018 | 425.53k | 0.09% |
| Kasikorn Asset Management Co., Ltd.as of 28 Dec 2023 | 46.50k | 0.01% |
| abrdn Alternative Investments Ltd.as of 31 Mar 2023 | 11.20k | 0.00% |
| FIL Investments Internationalas of 31 Dec 2023 | 0.00 | 0.00% |
